跳至主要内容
临床试验/NCT06593327
NCT06593327招募中不适用

Evaluation of a Pragmatic NT-ProBNP-based Heart Failure Screening Strategy Among Patients with Type 2 Diabetes: STRONG-DM Study (Screening and Treatment Using Risk-based ApprOach with NT-ProBNP Guidance in Diabetes Mellitus

University of Texas Southwestern Medical Center2 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2025年2月10日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
300
试验地点
2
主要终点
Incident Heart Failure or All-cause death

研究概览

简要总结

A pragmatic, randomized clinical trial to evaluate the effect of a heart failure (HF) risk assessment and prevention strategy incorporating HF clinical risk scores (WATCH-DM) with cardiac biomarker (NT-proBNP) paired with a clinical decision support tool to implement an intensive prevention strategy among patients with high risk focused on implementation of evidence-based HF preventive therapies.

详细描述

Primary care providers will be randomized to receive notifications via the electronic health record if any patients with diabetes have high heart failure risk based on a combination of clinical risk scores(WATCH-DM), and biomarkers (NT-proBNP). Providers will be provided recommendation to initiate evidence based therapies (SGLT2 inhibitors, GLP1 agonists, non-steroidal MRA) , obtain expert e-consultation, or refer the patient to a cardiometabolic risk management program.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

性别
All
接受健康志愿者

入选标准

  • Primary Care Provider that sees diabetes patients in clinic

排除标准

  • Provider does not see patients with Diabetes

结局指标

主要结局

Incident Heart Failure or All-cause death

时间窗: 2-year follow-up

Incident Heart Failure (based on electronic health record International Classification of Diseases codes) or all-cause death. This will be assessed via retrospective chart review.

次要结局

  • Prescription Rates of SGLT2i(6-months from electronic health record alert.)
  • Prescription Rate of Finerenone(6-months from electronic health record alert.)
  • Prescription Rate of GLP1(6-months from electronic health record alert.)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ambarish Pandey

Associate Professor of Internal Medicine

University of Texas Southwestern Medical Center

研究点 (2)

Loading locations...

相似试验